Flash-echo contrast sonography in the evaluation of response of small hepatocellular carcinoma to percutaneous ablation

Journal of Clinical Ultrasound

Volumn 34, Issue 4, 2006, Pages 161-168

  Wang, Jing Houng ^a   Lu, Sheng Nan ^a   Tung, Hung Da ^a   Changehien, Chi Sin ^a   Hung, Chao Hung ^a   Chen, Chien Hung ^a   Lee, Chuan Mo ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Biopsy; Contrast agents; Flash echo contrast ultrasonography; Hepatocellular carcinoma; Liver; Percutaneous ablation; Percutaneous ethanol injection; Percutaneous microwave ablation therapy; Tumors; Ultrasonography

Indexed keywords

ALCOHOL; ECHO CONTRAST MEDIUM; IOVERSOL; SHU 508;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOGRAPHY; FEMALE; FLASH ECHO CONTRAST ECHOGRAPHY; FOLLOW UP; HUMAN; INJECTION; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; MALE; MICROWAVE RADIATION; PERCUTANEOUS ETHANOL INJECTION; PERCUTANEOUS MICROWAVE ABLATION; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME; TUMOR RECURRENCE; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEOPLASMS, SECOND PRIMARY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33646577507     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20217     Document Type: Article

References (35)

1. Trevisani F, De Notariis S, Rapaccini G, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stages and patients survival (Italian experience). Am J Gastroenterol 2002;97:734.
2. Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis. Am J Med 1996;101:422.
3. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34:707.
4. Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous injection therapy. Cancer 1999; 85:1694.
5. Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999;210:655.
6. Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 1995;194:113.
7. Koito K, Namieno T, Ichimura T, et al. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy. AJR Am J Roentgenol 2000;174:337.
8. Kamiyama N, Moruyasu F, Mine Y, et al. Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic system. Ultrasound Med Biol 1998;25:411.
9. Wang JH, Lu SN, Changchien CS, et al. Flash-echo gray-scale imaging in the subtraction mode for assessing perfusion of small hepatocellular carcinoma. J Clin Ultrasound 2003;31:451.
10. Wang JH, Lu SN, Changchien CS, et al. Flash echo gray scale imaging with subtraction in assessment of small hepatocellular carcinoma treated with percutaneous ethanol injection-preliminary report. J Ultrasound Med 2001;20:539.
11. Bartolozzi C, Lencioni R, Caramella D, et al. Hepatocellular carcinoma: CT and MRI feature after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1994;191:123.
12. Tanaka S, Kitamra T, Fujita M, et al. Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler imaging. Radiology 1992;182:161.
13. Hosoki T, Mitomo M, Choi S, et al. Visualization of tumor vessels in hepatocellular carcinoma. Acta Radiol 1997;38:422.
14. Cosgrove DO, Blomley MJK, Jayaram V, et al. Echo-enhancing (contrast) agents. Ultrasound Q 1998;14:66.
15. Wilson SR, Burns PN. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging. Semin Liver Dis 2001;21:147.
16. Solbiati L, Goldberg SN, Lerace T, et al. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 1999;211:643.
17. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000;217:558.
18. Bartolozzi C, Lencioni R, Ricci P, et al. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 1998;209:387.
19. Kim AY, Chio BI, Kim TK, et al. Hepatocellular carcinoma: power Doppler US with a contrast agent-preliminary results. Radiology 1998;209:135.
20. Choi BI, Kim TK, Han JK, et al. Power versus conventional color Doppler sonography: Comparison in the depiction of vasculature in liver tumors. Radiology 1996;200:55.
21. Averkiou M, Powers J, Skyba D, et al. Ultrasound contrast imaging research. Ultrasound Q 2003;19:27.
22. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001;177:375.
23. Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003;181:57.
24. Youk JH, Lee JM, Kim CS. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging. J Ultrasound Med 2003; 22:911.
25. Morimoto M, Shirato K, Sugimori K, et al. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003;181:65.
26. Ding H, Kudo M, Onda H, et al. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic poser Doppler US during the early arterial phase in dual-display mode. Radiology 2001;220:349.
27. Rhim H, Goldberg SN, Dodd GD 3rd, et al. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics 2001;21:S17.
28. Ding H, Kudo M, Onda H, et al. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocelluar carcinoma. AJR Am J Roentgenol 2001;176:661.
29. Kojiro M, Yano H, Nakashima O. Pathology of hepatocellular carcinoma: progression from early to advanced. Semin Surg Oncol 1996;12:197.
30. Nakashima Y, Nakashima O, Hsia CC, et al. Vascularization of small hepatocellular carcinoma: correlation with differentiation. Liver 1999;19:12.
31. Khan KN, Yatsuhashi H, Yamasaki K, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000;32:269.
32. Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25:87.
33. Ishii H, Okada S, Nose H, et al. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996;77:1792.
34. Koda M, Murawaki Y, Mitsuda A, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection for small hepatocellular carcinoma. Cancer 2000;88:529.
35. Maeda T, Takenaka K, Taguchi K, et al. Small hepatocellular carcinoma with minute satellite nodules. Hepatogastroenterology 2000;47:1063.